IndegeneNSE:INDGN -0.23%49 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates NSE:INDGN with a GF Score™ of 49/100. The stock has 5 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Indegene ranks better than 89.79% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Indegene's Free Cash Flow for the
three
months ended in Mar. 2026 was ₹0 Mil. Indegene's Revenue for the
three
months ended in Mar. 2026 was ₹10,034 Mil. Therefore, Indegene's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Indegene's FCF Margin % or its related term are showing as below:
NSE:INDGN'
s FCF Margin % Range Over the Past 10 Years
Min: 4.83 Med: 16.02 Max: 19.19
Current: 17.27
During the past 6 years, the highest FCF Margin % of Indegene was 19.19%. The lowest was 4.83%. And the median was 16.02%.
NSE:INDGN's FCF Margin % is ranked better than 89.79% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 3.06
vs NSE:INDGN: 17.27
Indegene FCF Margin % Related Terms
Indegene FCF Margin % Historical Data
* Premium members only.
The historical data trend for Indegene's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDGN vs VEEV, BTSG, TEM: FCF Margin % Comparison
For the Health Information Services subindustry, Indegene's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indegene FCF Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Indegene's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Indegene's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indegene (NSE:INDGN) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Indegene and its competitors. Over the past decade, Indegene's FCF Margin % has ranged from 4.83 to 19.19. According to the industry distribution chart, Indegene ranks #68 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 10.2%.
Is Indegene's FCF Margin % too high?
Indegene's current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 4.83 to a high of 19.19. Based on the distribution chart, Indegene ranks #68 out of 666 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Indegene has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does Indegene's FCF Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Indegene ranks #68 out of 666 companies for FCF Margin %. This places Indegene in the top 10% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 3.06. Historically, Indegene's own FCF Margin % has ranged from 4.83 to 19.19 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Healthcare Providers & Services company?
The median FCF Margin % among Healthcare Providers & Services companies is 3.06, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Indegene and its competitors. For the Healthcare Providers & Services industry, the median FCF Margin % is 3.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indegene's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indegene stock overvalued right now?
Indegene (NSE:INDGN) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Indegene's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Indegene (NSE:INDGN), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical device companies. It assists them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations for life sciences companies. The company's segments include Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment. The company has a presence in India, Europe, and North America, with the majority of revenue coming from North America.
49GF Score
Get the complete analysis for NSE:INDGN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDGN has been successfully added to your 
